PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: A new approach

Journal of Alzheimer's Disease

Volumn 42, Issue 3, 2014, Pages 757-760

  Delabio, Roger ^a   Rasmussen, Lucas ^b   Mizumoto, Igor ^a   Viani, Gustavo Arruda ^a   Chen, Elizabeth ^c   Villares, João ^c   Costa, Isabela Bazzo ^a   Turecki, Gustavo ^d   Linde, Sandra Aparecido ^e   Smith, Marilia Cardoso ^c   Payão, Spencer Luiz ^a,b  

^a FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^b Universidades Do Sagrado Cora cão   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d MCGILL UNIVERSITY   (Canada)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alzheimer's disease; brain; gene expression; presenilin 1; presenilin 2; secretase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; PRESENILIN 1; PRESENILIN 2; RNA; ARABIDOPSIS PROTEIN; MARNERAL SYNTHASE, ARABIDOPSIS; MUTASE;

ALZHEIMER DISEASE; ARTICLE; AUDITORY CORTEX; BRAIN TISSUE; ENTORHINAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; NEUROTRANSMISSION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; AGED; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARABIDOPSIS PROTEINS; BRAIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRAMOLECULAR TRANSFERASES; MALE; PRESENILIN-1; PRESENILIN-2;

EID: 84907141350     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140033     Document Type: Article

References (13)

1. Selkoe DJ (2001) Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 3, 75-80.
2. Bradley-Whitman MA, Lovell MA (2013) Epigenetic changes in the progression of Alzheimer's disease. Mech Ageing Dev 134, 486-495.
3. Bloom GS(2014) Amyloid-and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71, 505-508.
4. Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N (2011) Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet 20, 4530-4539.
5. Cacquevel M, Aeschbach L, Houacine J, Fraering PC (2012) Alzheimer's disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified c-secretase complexes. Plos One 7, e35133.
6. Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S (2012) Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci 39, 436-445.
7. Walker ES, Martinez M, Brunkan AL, Goate A (2005) Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in A-42/40 ratios. J Neurochem 92, 294-301.
8. Li T, Li YM, Ahn K, Price DL, Sisodia SS, Wong PC (2011) Increased expression of PS1 is sufficient to elevate the level and activity of c-secretase in vivo. PLoS ONE 6, e28179.
9. Chen Y, Tian Z, Liang Z, Sun S, Dai CL, Lee MH, LaFerla FM, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX (2012) Brain gene expression of a sporadic (icv-STZ mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer's disease. PLoS ONE 7, e51432.
10. Mohuczy D, Qian K, Phillips MI (2002) Presenilins in the heart: Presenilin-2 expression is increased by lowglucose and by hypoxia in cardiac cells. Regul Pept 110, 1-7.
11. Park MH, Choi DY, Jin HW, Yoo HS, Han JY, Oh KW, Han SB, Hwang DY, Hong JT (2012) Mutant presenilin 2 increases a-secretase activity through reactive oxygen species dependent activation of extracellular signal regulated kinase. J Neuropathol Exp Neurol 71, 130-139.
12. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R,MühleisenTW,NöthenMM,Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O'Donovan MC, Owen MJ, Williams J (2012) The role of variation at A-PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis 28, 377-387.
13. Tan MG, Chua WT, Esiri MM, Smith AD, Vinters HV, Lai MK(2010) Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J Neurosci Res 88, 1157-1169.